HOW PHARMA LEADERS MAKE DECISIONS BEFORE CERTAINTY EXISTS
The Decision SIGNALS.
Signals from Physicians, Payers, and Markets Shape Access, Pricing, and Commercial Decisions Long Before Formal Data is Complete.
-
The Decision Signals builds on published work in decision-making in pharma, focusing on how leaders interpret signals and act before certainty exists.
-
The platform combines structured thinking, real-world observations, and leadership perspectives to better understand how critical decisions are formed.
Some discussions explored through The Decision Signals continue in more focused working environments with selected teams.
-
The Decision Signals is built for leaders across pharma from commercial market access and medical who are responsible for interpreting change and making informed decisions in complex environments.
-
We curate insights from industry leaders, published experience, interviews, and targeted research distilling them into concise observations that surface what matters early.
This work extends into practice, supporting teams across multinational Pharma organisations through structured market dynamics research and analysis that helps interpret complex markets and apply insight in real decision-making contexts.
The Decision Signals Review is a publication featuring leadership perspectives and real-world decision patterns on Pharma
Latest SIGNALS.
-
![]()
“ remain neutral upon your first examination of data ”
-
![]()
“ Are You More Confident Than Correct? ”
-
![]()
“ Fall-Back Options ”
-
![]()
“ limit your business ambition ”
-
![]()
“ Avoid being caught in The Intelligence Trap ”
-
![]()
"follow three conclusions"
-
![]()
"select your primary opportunities"
-
![]()
“ Live in the Question of Not Knowing ”
-
![]()
"make alliances & partnerships"
THE PROBLEM.
Decisions are made before the data is ready
In pharma, key commercial decisions are rarely made with complete information. Launch assumptions, pricing expectations, and access strategies are often shaped early, based on fragmented signals, informal feedback, and partial evidence.
These early signals, however, are frequently misunderstood, over-relied on, or overlooked altogether. The Decision Signals focuses on how such signals are gathered, interpreted, and ultimately influence real-world decisions—long before certainty exists.
Decision FRAMEWORKS
The Decision Signals introduces practical frameworks for interpreting signals and navigating uncertainty in access, pricing, and launch strategy.
These frameworks help pharma leaders:
Distinguish signal from noise
Challenge early assumptions
Understand where confidence may be misplaced
Navigate decision risk before it becomes visible
Upcoming Events
Executive Decision Sessions
September 15th 2026
These sessions explore how decisions are made in practice before data is complete and when signals are ambiguous. They draw on frameworks developed through published work and real-world experience across access and commercial strategy.
60 minutes. Focused, Practical Discussion.
Who We Are
The Decision Signals Review. builds on published work in pharmaceutical decision-making, focusing on how leaders interpret signals and act before certainty exists.
The platform combines structured thinking, real-world observations, and leadership perspectives to better understand how critical decisions are made.
Some discussions introduced through The Decision Signals continue in more focused working environments with selected teams.
become a contributor
THE DECISION SIGNALS REVIEW.
The Decision Signals Review is built on original thinking. For this reason, contributors are carefully selected through stringent criteria.
We are looking for people who can bring depth, clarity, and meaningful insight. Every contributor is reviewed based on their expertise, quality of thinking, originality, and ability to help others make better decisions.
The Decision Signals Review is a curated space for selected voices who can add real value.
If you believe your thinking meets that standard, we invite you to apply.